Xylem (NYSE:XYL – Get Rating) updated its FY22 earnings guidance on Wednesday. The company provided earnings per share guidance of $2.40-2.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.55. The company issued revenue guidance of +1-3% yr/yr to ~$5.25-5.35 billion, compared to the consensus revenue estimate of $5.34 billion.
XYL opened at $82.37 on Wednesday. The company has a 50 day simple moving average of $85.75 and a two-hundred day simple moving average of $105.09. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.27 and a quick ratio of 1.77. The firm has a market cap of $14.83 billion, a P/E ratio of 35.05, a PEG ratio of 2.66 and a beta of 1.08. Xylem has a 1-year low of $80.00 and a 1-year high of $138.78.
Xylem (NYSE:XYL – Get Rating) last issued its earnings results on Wednesday, May 4th. The industrial products company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.06. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.24 billion. Xylem had a net margin of 8.22% and a return on equity of 14.67%. Xylem’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.56 EPS. Equities analysts anticipate that Xylem will post 2.52 earnings per share for the current year.
Several research analysts have weighed in on XYL shares. Stifel Nicolaus dropped their price target on Xylem from $100.00 to $90.00 and set a hold rating for the company in a research note on Monday, April 18th. Morgan Stanley cut their target price on shares of Xylem from $120.00 to $110.00 and set an overweight rating for the company in a research note on Monday, April 18th. Credit Suisse Group decreased their price target on shares of Xylem from $111.00 to $98.00 and set an underperform rating on the stock in a research note on Friday, February 4th. Raymond James upgraded Xylem from an underperform rating to a market perform rating in a research report on Tuesday, April 5th. Finally, Zacks Investment Research upgraded Xylem from a strong sell rating to a hold rating and set a $92.00 target price on the stock in a research report on Wednesday, April 6th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Xylem has an average rating of Hold and a consensus target price of $114.45.
In other Xylem news, SVP Colin R. Sabol sold 4,233 shares of the firm’s stock in a transaction dated Monday, April 18th. The shares were sold at an average price of $83.05, for a total value of $351,550.65. Following the completion of the sale, the senior vice president now owns 27,373 shares of the company’s stock, valued at $2,273,327.65. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.89% of the stock is currently owned by company insiders.
Several institutional investors and hedge funds have recently modified their holdings of XYL. EverSource Wealth Advisors LLC bought a new stake in Xylem during the 4th quarter valued at $66,000. Flagship Harbor Advisors LLC bought a new stake in shares of Xylem in the fourth quarter valued at about $214,000. Bank Julius Baer & Co. Ltd Zurich lifted its stake in Xylem by 100.0% in the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,000 shares of the industrial products company’s stock worth $240,000 after acquiring an additional 1,000 shares during the period. Autumn Glory Partners LLC purchased a new stake in Xylem in the fourth quarter worth about $302,000. Finally, Peapack Gladstone Financial Corp grew its holdings in Xylem by 5.8% during the 4th quarter. Peapack Gladstone Financial Corp now owns 2,718 shares of the industrial products company’s stock worth $326,000 after acquiring an additional 150 shares in the last quarter. 83.83% of the stock is owned by hedge funds and other institutional investors.
Xylem Company Profile (Get Rating)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.
- Get a free copy of the StockNews.com research report on Xylem (XYL)
- What’s Next For Starbucks (NASDAQ: SBUX)?
- 3 Earnings Plays With Big Move Potential
- There Are Weeds In The Garden At Scotts Miracle-Gro
- It’s Time For FuboTV to Stand Out in the Sea of Streaming
- Landstar Systems Stock Can Bottom Down Here
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.